FIELD: medicine, infectious immunology.
SUBSTANCE: it is necessary to carry out symptomatic treatment and immunocorrection due to rectal introduction of Kipferon in suppositories at daily dosage of 1 mln IU twice daily, in 12 h for 7 d. The innovation provides antiproliferative effect at early stages of the disease mentioned due to complex substitution of some immunoglobulins.
EFFECT: higher efficiency of therapy.
3 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2003 |
|
RU2242983C1 |
| METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
| METHOD FOR ASSESSING DEGREE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2017 |
|
RU2673073C1 |
| METHOD OF ASSESSING THE QUALITY OF RECONVALESCENCE IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2018 |
|
RU2703705C1 |
| METHOD FOR CHRONIC INFECTIOUS MONONUCLEOSIS SEVERITY DETERMINATION IN CHILDREN | 2009 |
|
RU2406433C1 |
| METHOD FOR PREDICTING INFECTIOUS MONONUCLEOSIS FLOW IN CHILDREN | 2004 |
|
RU2279677C1 |
| METHOD OF FORECASTING SERIOUSNESS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360255C1 |
| METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
| METHOD OF DIAGNOSING SEVERE FORMS OF INFECTION OF MONONUCLEOSIS CAUSED BY VIRUS EPSTEIN-BARR IN BABIES | 2000 |
|
RU2172956C1 |
| METHOD FOR PATHOGENETIC CORRECTION OF METABOLIC DISORDERS IN INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS | 2020 |
|
RU2726070C1 |
